# ⚠️ CRITICAL CLINICAL SAFETY NOTICE

**Last Updated:** 2026-01-12 22:57:39 UTC

---

## DISCLAIMER: NOT FOR DIRECT CLINICAL USE

This AI system is a **DECISION SUPPORT TOOL ONLY** and must NOT be used as the sole basis for clinical decision-making, medication selection, treatment planning, or patient care decisions.

---

## CRITICAL SAFETY WARNINGS

### 1. FDA Regulatory Compliance
- This system is not FDA-cleared or approved for autonomous clinical decision-making
- All outputs must be reviewed and validated by licensed healthcare professionals
- Users are responsible for compliance with applicable regulatory requirements
- Do not use in clinical settings without proper institutional review and approval

### 2. Clinical Limitations
- **AI Cannot Replace Professional Judgment:** The system may miss critical clinical context, atypical presentations, or rare conditions
- **No Real-Time Patient Monitoring:** This system cannot monitor patients in real-time or detect acute deterioration
- **Limited Drug Interaction Knowledge:** While comprehensive, the database may not contain all known interactions, contraindications, or adverse effects
- **Personalization Gaps:** The system cannot account for all individual patient factors (genetics, comorbidities, social determinants)

### 3. High-Risk Scenarios
⛔ **DO NOT use this system without immediate physician oversight for:**
- Pediatric patients (especially neonates and infants)
- Pregnant or lactating women
- Patients with severe renal or hepatic impairment
- Patients on complex polypharmacy (>10 medications)
- Emergency situations or acute decompensation
- Immunocompromised patients
- Patients with genetic/metabolic disorders
- Elderly patients with cognitive impairment

### 4. Known System Limitations
- May not recognize off-label use complications
- Limited understanding of medication formulation differences
- Cannot assess adherence barriers or medication access issues
- May not account for regional/formulary differences
- Cannot substitute for clinical trials or formal clinical guidelines

---

## EMERGENCY PROCEDURES

### Immediate Medical Emergency
**If a patient is experiencing a medical emergency:**

1. **STOP using this system immediately**
2. **CALL EMERGENCY SERVICES (911 in US, 999 in UK, 112 in EU)**
3. **Contact the treating physician or nearest emergency department**
4. **Do NOT wait for AI system analysis**

### Adverse Drug Event Reporting
If an adverse event is suspected:

1. **Ensure patient safety first** - provide appropriate medical intervention
2. **Contact poison control if applicable:** US 1-800-222-1222 (24/7)
3. **Report to FDA MedWatch:** https://www.fda.gov/medwatch
4. **Report to your institution's pharmacovigilance team**
5. **Document all details** for healthcare provider review

### System Malfunction or Unreliable Output
If you notice:
- Inconsistent recommendations for identical inputs
- Recommendations contradicting established clinical guidelines
- Missing or incorrect drug information
- System errors or crashes

**Take these steps:**
1. Stop using the system immediately
2. Document the issue with screenshots and inputs
3. Contact the development team at: [INSERT SUPPORT EMAIL]
4. Escalate to your institution's clinical informatics team
5. Revert to manual reference sources and expert consultation

---

## REQUIRED USER QUALIFICATIONS

Users of this system MUST:
- [ ] Be a licensed healthcare professional (MD, DO, PharmD, RN, or equivalent)
- [ ] Have completed training on this specific system
- [ ] Understand the system's limitations and intended use
- [ ] Have access to clinical decision support resources and expert consultation
- [ ] Be familiar with current clinical practice guidelines
- [ ] Have institutional authorization to use this tool
- [ ] Maintain professional liability insurance

---

## PROPER USAGE GUIDELINES

### ✓ APPROVED USES
- Educational reference for healthcare professionals
- Decision support to augment (not replace) clinical judgment
- Literature review and evidence gathering
- Identification of potential drug-drug interactions for professional review
- Continuing medical education
- Research and quality improvement activities

### ✗ PROHIBITED USES
- Direct patient care decision-making without physician review
- Clinical decisions for patients the user has not personally evaluated
- Use by non-licensed individuals
- Use in systems without proper governance oversight
- Autonomous prescribing or medication selection
- Patient-facing recommendations without healthcare provider intermediation
- Use in medical devices without regulatory approval

---

## DATA SECURITY AND CONFIDENTIALITY

### Protected Health Information (PHI)
- **NEVER input actual patient data** (names, medical record numbers, dates of birth)
- Use de-identified patient information only
- The system may log interactions for quality improvement
- Assume no guarantee of confidentiality
- Comply with HIPAA, GDPR, and applicable privacy regulations

### Data Handling
- Do not use for patients with sensitive/restricted conditions (HIV, mental health, etc.) without proper safeguards
- Ensure institutional approval for any patient data use
- Implement appropriate access controls
- Maintain audit trails as required by law

---

## CLINICAL VALIDATION CHECKLIST

Before implementing ANY recommendation from this system, verify:

- [ ] **Dosing:** Compare against current drug reference (e.g., UpToDate, Micromedex)
- [ ] **Contraindications:** Review patient's complete medical history
- [ ] **Drug Interactions:** Cross-reference with primary sources
- [ ] **Allergies/Sensitivities:** Confirm no documented allergies to recommended agents
- [ ] **Renal/Hepatic Function:** Adjust dosing if needed; check clearance data
- [ ] **Age Appropriateness:** Verify recommendations for pediatric/geriatric patients
- [ ] **Pregnancy/Lactation:** Confirm safety in pregnant/nursing patients
- [ ] **Drug Interactions:** Check for interactions with ALL patient medications
- [ ] **Recent Guidelines:** Verify alignment with current clinical practice guidelines
- [ ] **Institutional Policies:** Confirm alignment with your facility's protocols

---

## SUPPORT AND REPORTING

### Questions or Concerns?
- Contact your institution's clinical pharmacist
- Consult your hospital's informatics or quality improvement department
- Review current clinical practice guidelines (ACCP, ACP, NCCN, etc.)
- Escalate to your clinical leadership or patient safety officer

### Report Issues
- **Technical Issues:** [INSERT TECHNICAL SUPPORT EMAIL]
- **Clinical Safety Concerns:** [INSERT CLINICAL SAFETY EMAIL]
- **Privacy/Security:** [INSERT SECURITY EMAIL]
- **Adverse Events:** Contact your institution's pharmacovigilance team

---

## LIABILITY AND LEGAL NOTICE

### User Responsibility
The user assumes full responsibility for:
- All clinical decisions and recommendations
- Appropriateness of use in their clinical context
- Compliance with applicable laws and regulations
- Professional judgment and oversight
- Patient outcomes and adverse events

### No Warranty
This system is provided "AS IS" without warranty of:
- Accuracy, completeness, or timeliness of information
- Suitability for any particular purpose
- Freedom from errors or omissions
- Fitness for clinical use

### Limitation of Liability
The developers, sponsors, and affiliated institutions are not liable for:
- Patient harm or adverse outcomes
- Incorrect clinical decisions based on system output
- Regulatory violations or legal liability
- Data breaches or privacy violations
- System errors or downtime

---

## ACKNOWLEDGMENT OF UNDERSTANDING

**Users must acknowledge that they:**
1. Understand this is a decision support tool, not a clinical decision maker
2. Will not use this system as the sole basis for patient care
3. Will obtain proper clinical oversight and validation
4. Will follow all applicable laws, regulations, and institutional policies
5. Accept responsibility for all clinical decisions
6. Will immediately escalate to emergency protocols if needed
7. Understand the risks and limitations outlined in this notice

---

## VERSION HISTORY

| Version | Date | Changes |
|---------|------|---------|
| 1.0 | 2026-01-12 | Initial critical safety notice creation |

---

## RELATED DOCUMENTS
- [CONTRIBUTING.md](CONTRIBUTING.md) - Development guidelines
- [CODE_OF_CONDUCT.md](CODE_OF_CONDUCT.md) - Community standards
- [LICENSE](LICENSE) - Legal licensing information
- Clinical validation protocols (internal documentation)
- Institutional use agreements (institutional specific)

---

**⚠️ CRITICAL REMINDER:** When in doubt, consult with licensed healthcare professionals and current clinical resources. Patient safety is paramount.

*This notice was generated on 2026-01-12 22:57:39 UTC and reflects current understanding. Updates to clinical knowledge may supersede information in this document.*
